Motoi Kanagawa Selected Research

Motoi Kanagawa Research Topics

Disease

28	Muscular Dystrophies (Muscular Dystrophy) 12/2023 - 07/2002
8	Walker-Warburg Syndrome 01/2018 - 12/2006
3	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 08/2011 - 02/2009
2	Muscular Diseases (Myopathy) 01/2022 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 11/2018 - 11/2013
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 08/2022
1	Antisynthetase syndrome 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Inclusion Body Myositis 01/2022
1	Polymyositis 01/2022
1	Heterotopic Ossification (Ectopic Ossification) 01/2021
1	Dementia (Dementias) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Multiple System Atrophy 01/2019
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2019
1	Melanoma (Melanoma, Malignant) 11/2018
1	Malformations of Cortical Development 01/2018
1	Lissencephaly 03/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2013
1	Arenaviridae Infections 10/2011
1	Hypercholesterolemia 10/2011
1	Type 1C Limb-Girdle Muscular Dystrophy 08/2011
1	Cognitive Dysfunction 03/2011
1	Eye Abnormalities (Eye Abnormality) 10/2010
1	Pheochromocytoma 06/2007
1	Lassa Fever (Fever, Lassa) 11/2005
1	Carcinoma (Carcinomatosis) 09/2004

Drug/Important Bio-Agent (IBA)

23	Dystroglycans (Dystroglycan)IBA 01/2022 - 07/2002
8	Laminin (Merosin)IBA 08/2022 - 07/2004
7	Polysaccharides (Glycans)IBA 12/2023 - 07/2004
6	RibitolIBA 01/2022 - 03/2016
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2005
5	Phosphates (Orthophosphate)IBA 01/2022 - 03/2016
4	GlycosyltransferasesIBA 01/2016 - 07/2004
4	LigandsIBA 03/2012 - 07/2002
2	EnzymesIBA 01/2022 - 01/2006
2	TransferasesIBA 01/2020 - 01/2018
2	Mannose (D-Mannose)IBA 01/2016 - 10/2010
2	protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA 01/2016 - 10/2010
1	SpectrinIBA 08/2022
1	SteroidsIBA 08/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Terpenes (Terpenoids)IBA 01/2022
1	cytidine diphosphate ribitolIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	ProdrugsIBA 01/2022
1	lubricinIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	alpha-SynucleinIBA 01/2019
1	dabrafenibIBA 11/2018
1	Proto-Oncogene Proteins B-rafIBA 11/2018
1	NeurotoxinsIBA 11/2018
1	PolymersIBA 02/2015
1	Insulin-Like PeptidesIBA 09/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2014
1	DysferlinIBA 01/2014
1	SynucleinsIBA 11/2013
1	Epidermal Growth Factor (EGF)IBA 10/2013
1	Alanine (L-Alanine)FDA Link 10/2013
1	O-GlcNAc transferaseIBA 10/2013
1	MM Form Creatine KinaseIBA 08/2013
1	TB-403IBA 10/2011
1	Retroelements (Retrotransposon)IBA 10/2011
1	LipidsIBA 10/2011
1	Caveolin 3IBA 08/2011
1	Retinaldehyde (Retinal)IBA 08/2008
1	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2007
1	Glycoproteins (Glycoprotein)IBA 01/2006
1	CollagenIBA 01/2006
1	DystrophinIBA 01/2006
1	Cell Surface ReceptorsIBA 11/2005
1	Peptide Hydrolases (Proteases)FDA Link 09/2004

Therapy/Procedure

4	Therapeutics 08/2022 - 04/2013
1	Ligation 01/2019